Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Fraggetta

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|October 5, 2020
Expression of miR-132 and miR-212 in prostate cancer and metastatic lymph node: Case report and revision of the literatureMichele Salemi, Angela Pettinato, Filippo Fraggetta, et al.
Journal of Clinical Pathology|May 8, 2016
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patientsGian Franco Zannoni, Giuseppina Improta, Angela Pettinato, et al.
Oncology Letters|February 13, 2016
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significanceGiuseppina Improta, Angela Pettinato, Stefania Gieri, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivoGiuseppina Improta, Cathrin Ritter, Angela Pettinato, et al.
Oncoimmunology|November 2, 2013
Biological insights into BRAF<sup>V600</sup> mutations in melanoma patient: Not mere therapeutic targetsGiuseppina Improta, Giuseppe Pelosi, Elena Tamborini, et al.
Frontiers in Medicine|August 17, 2019
The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With ImmunotherapyGiuseppe Luigi Banna, Timothée Olivier, Francesco Rundo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 10, 2018
Ovarian Clear Cell Carcinoma: From Morphology to Molecular BiologyGiuseppina Improta, Angela Pettinato, Estrid Høgdall, et al.
Gynecologic Oncology|February 7, 2025
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)Gian Franco Zannoni, Giuseppe Angelico, Saveria Spadola, et al.
Oncology Letters|November 20, 2012
Dermatofibrosarcoma protuberans: Our experience of 59 casesAlessio Stivala, Giuseppe A G Lombardo, Gianluca Pompili, et al.
The International Journal of Biological Markers|December 25, 2013
Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell linesMichele Salemi, Filippo Fraggetta, Antonio Galia, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|October 5, 2020
Expression of miR-132 and miR-212 in prostate cancer and metastatic lymph node: Case report and revision of the literatureMichele Salemi, Angela Pettinato, Filippo Fraggetta, et al.
Journal of Clinical Pathology|May 8, 2016
Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patientsGian Franco Zannoni, Giuseppina Improta, Angela Pettinato, et al.
Oncology Letters|February 13, 2016
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significanceGiuseppina Improta, Angela Pettinato, Stefania Gieri, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivoGiuseppina Improta, Cathrin Ritter, Angela Pettinato, et al.
Oncoimmunology|November 2, 2013
Biological insights into BRAF<sup>V600</sup> mutations in melanoma patient: Not mere therapeutic targetsGiuseppina Improta, Giuseppe Pelosi, Elena Tamborini, et al.
Frontiers in Medicine|August 17, 2019
The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With ImmunotherapyGiuseppe Luigi Banna, Timothée Olivier, Francesco Rundo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 10, 2018
Ovarian Clear Cell Carcinoma: From Morphology to Molecular BiologyGiuseppina Improta, Angela Pettinato, Estrid Høgdall, et al.
Gynecologic Oncology|February 7, 2025
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)Gian Franco Zannoni, Giuseppe Angelico, Saveria Spadola, et al.
Oncology Letters|November 20, 2012
Dermatofibrosarcoma protuberans: Our experience of 59 casesAlessio Stivala, Giuseppe A G Lombardo, Gianluca Pompili, et al.
The International Journal of Biological Markers|December 25, 2013
Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell linesMichele Salemi, Filippo Fraggetta, Antonio Galia, et al.
Pageof 13